- Volume 13 Issue 12
DOI QR Code
Clinical Significance of Quantitative Analysis of Plasma Epstein-Barr Virus DNA in Patients of Xinjiang Uygur Nationality with Hodgkin's Lymphoma
- Li, Xun (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Yang, Shun-E. (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Guo, Yun-Quan (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Shen, Ming-Xia (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Gu, Li (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Gulikezi, Gulikezi (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Zhao, Bing (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Liu, Wei (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Tuerxun, Tuerxun (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) ;
- Bai, Jing-Ping (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University)
- 발행 : 2012.12.31
Objective: To investigate the relationship between plasma EBV-DNA concentration and clinicopathologic features of Hodgkin's lymphoma cases. Methods: At first, the positive rate of plasma EBV-DNA was determined with a nested-PCR method using 45 specimens from Uygur HL patients, as well as 110 healthy people sampled as normal controls. Secondly, using fluorescent quantitative nested-PCR, EBV viral load was assessed in the EBV-DNA positive plasma samples. Then, relationships between plasma EBV viral load and clinicopathologic features of HL patients were analyzed. Results: The positive rate of plasma EBV-DNA of HL patients was significantly higher than that of normal controls (53.3% vs 26.4%, P=0.001). There was no significant difference about plasma EBV viral load between EBV-associated HL and EBV-DNA positive normal people (P=0.490). Looking at patients' characteristics, plasma EBV viral load in 10-20 years EBV-associated HL was higher than in EBV cases which were less than 10 years or more than 35 years (P=0.025). Furthermore, in EBV-associated HL, concentration of plasma EBV-DNA was significantly higher in advanced stage disease (stages III-IV; P=0.013), and with B-symptoms (P=0.020). Conclusion: EBV-DNA levels were associated with part of clinicopathologic features of cases. It was of practical use to screen HL. Further etiological studies appear warranted.
Hodgkin's lymphoma;Uygur nationality;nested-PCR;Epstein-Barr virus p1asma viral load
- Massini G, Siemer D, Hohaus S (2009). EBV in hodgkin lymphoma. Mediterr J Hematol Infect Dis, 1, e2009013.
- Musacchio JG, Carvelho Mda G, Morais JC, et al (2006). Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin's disease. Sao Paulo Med J, 124, 154-7.
- Pajand O, Pourakbari B, Mahjob F, et al (2011). Detection of Epstein-Barr virus DNA in plasma and lymph node biopsy samples of pediatric and adult patients with Hodgkin lymphoma. Pediatr Hematol Oncol, 28, 10-5. https://doi.org/10.3109/08880018.2010.507691
- Spacek M, Hubacek P, Markova J, et al (2011). Plasma EBVDNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients. APMIS, 119, 10-6.
- Umetani N, Hiramatsu S, Hoon DS (2006). Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann N Y Acad Sci, 1075, 299-307. https://doi.org/10.1196/annals.1368.040
- Wagner HJ, Schlager F, Claviez A, Bucsky P (2001). Detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction. Eur J Cancer, 37, 1853-7. https://doi.org/10.1016/S0959-8049(01)00152-6
- Wagner HJ, Wessel M, Jabs W, et al (2001). Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation, 72, 1012-9. https://doi.org/10.1097/00007890-200109270-00006
- Zhou XG, Sandvej K, Li PJ, et al (2001). Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin disease: Hodgkin disease in young children is an EBV-related lymphoma. Cancer, 92, 1621-31. https://doi.org/10.1002/1097-0142(20010915)92:6<1621::AID-CNCR1488>3.0.CO;2-P
- Anker P, Mulcahy H, Chen XQ, Stroun M (1999). Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev, 18, 65-73. https://doi.org/10.1023/A:1006260319913
- Chabay PA, Barros MH, Hassan R, et al (2008). Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol, 30, 285-91. https://doi.org/10.1097/MPH.0b013e3181647bc3
- Chan A, Zhung J, Chan A, et al (2003). Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res, 63, 2028-32.
- Dinand V, Arya LS (2006). Epidemiology of childhood hodgkins disease: is it different in developing countries? Indian Pediatr, 43, 141-7.
- Gallagher A, Armstrong AA, MacKenzie J, et al (1999). Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer, 84, 442-8. https://doi.org/10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.0.CO;2-J
- Gandhi MK, Lambley E, Burrows J, et al (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res, 12, 460-4. https://doi.org/10.1158/1078-0432.CCR-05-2008
- Halliday C, Wu QX, James G, Sorrell T (2005).Development of a nested qualitative real-time PCR assay to detect Aspergillus species DNA in clinical specimens. J Clin Microbiol, 43, 5366-8. https://doi.org/10.1128/JCM.43.10.5366-5368.2005
- Hohaus S, Santangelo R, Giachelia M, et al (2011). The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res, 17, 2885-92. https://doi.org/10.1158/1078-0432.CCR-10-3327
- Huang X, Hepkema B, Nolte I, et al (2012). HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China. PLoS One, 7, e31865. https://doi.org/10.1371/journal.pone.0031865
- Huang X, Nolte I, Gao Z, et al (2011). Epidemiology of classical hodgkin lymphoma and its association with epstein barr virus in northern China. PLoS One, 6, e21152. https://doi.org/10.1371/journal.pone.0021152
- Ishii H, Ogino T, Berger C, et al (2007). Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma. J Med Virol, 79, 562-72. https://doi.org/10.1002/jmv.20853
- Jarrett RF (2003). Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leuk Lymphoma, 44, S27-32. https://doi.org/10.1080/10428190310001623801
- Le QT, Jones CD, Yau TK, et al (2005). A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma. Clin Cancer Res, 11, 5700-7. https://doi.org/10.1158/1078-0432.CCR-05-0648
- Lo YM, Chan LY, Lo KW, et al (1999). Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res, 59, 1188-91.
- Type Distribution of Lymphomas in Lebanon: Five-Year Single Institution Experience vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5825
- Frequency and Pattern of Bone Marrow Infiltration in Classical Hodgkin's Lymphoma: Experience from Southern Pakistan vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1857